Medscape

Long-term dofetilide treatment linked to increased risk of torsade de pointes

Nashville, TN - In one of the first studies to look at the long-term effects of dofetilide (Tikosyn? - Pfizer) in patients with left ventricular dysfunction and implantable cardioverter-defibrillators ...
Medscape

A Case of Vagally Mediated Idiopathic Ventricular Fibrillation

We report a case of vasovagal syncope caused by serious ventricular arrhythmias, which were triggered by PVCs originating from the RVOT. Intravenous administration of edrophonium chloride reproducibly ...
Nasdaq

Solid Biosciences to Initiate Phase 1b Trial for SGT-501, a Novel Gene Therapy for Catecholaminergic Polymorphic Ventricular Tachycardia

Solid Biosciences announces Phase 1b trial for SGT-501, a gene therapy for catecholaminergic polymorphic ventricular tachycardia, with FDA designations. Solid Biosciences Inc. has announced the ...
Seeking Alpha

Solid Biosciences Receives FDA Fast Track Designation for SGT-501 First-in-Class Gene Therapy for Catecholaminergic Polymorphic Ventricular Tachycardia (CPVT)

- Potential first-in-class therapy with FDA IND clearance and Health Canada CTA approval designed to address underlying causes of CPVT, a life-threatening, arrhythmogenic cardiac condition - - Solid ...
Medical Xpress

Polymorphic Catecholaminergic Ventricular Tachycardia

Researchers have developed a novel method for simultaneously recording action potentials (APs)—temporary changes in electrical potential when cells become excited—and calcium transients—calcium ...